☆ 4.8 Editorial Material

Response: Commentary: An In Silico- In Vitro Pipeline Identifying an HLA-A*02:01+KRAS G12V+Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

FRONTIERS IN IMMUNOLOGY (2021)

Get Full Text
Add to Collection

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.679836

Keywords

proteasome; peptide splicing; antigen presentation; tumor immunology; mass spectrometry

Categories

Immunology

Funding

  1. MPI-BPC collaboration agreement 2020, Cancer Research UK [C67500, A29686]
  2. National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London
  3. ERC-StG [945528]
  4. European Research Council (ERC) [945528] Funding Source: European Research Council (ERC)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.